A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial
一项关于替莫唑胺作为晚期神经内分泌癌二线治疗方案的新型给药方案（TENEC试验）：一项多中心、开放标签、单臂II期临床试验。该方案采用一周用药/一周停药的给药方式。
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103003
von Arx, C; Della Vittoria Scarpati, G; Cannella, L; Clemente, O; Marretta, A L; Bracigliano, A; Picozzi, F; Iervolino, D; Granata, V; Modica, R; Bianco, A; Mocerino, C; Di Mauro, A; Pizzolorusso, A; Di Sarno, A; Ottaiano, A; Tafuto, S
